Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial-Reference-Cited by-同舟云学术

Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial

Published:2018-09-17 Issue:11 Volume:103 Page:4176-4186
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Braun Laurie R¹²,Feldpausch Meghan N¹,Czerwonka Natalia¹,Weiss Julian¹,Branch Karen³,Lee Hang⁴,Martinez-Salazar Edgar L⁵,Torriani Martin⁵,Sponseller Craig A⁶,Grinspoon Steven K¹,Stanley Takara L¹²^ORCID

Affiliation:

1. Program in Nutritional Metabolism and Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

2. Department of Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

3. Clinical Research Center, Massachusetts General Hospital, Boston, Massachusetts

4. Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

5. Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

6. Kowa Pharmaceuticals America, Montgomery, Alabama

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Kowa Pharmaceuticals America

National Institutes of Health

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/103/11/4176/26109400/jc.2018-01446.pdf

Reference46 articles.

1. Pleiotropic effects of statins in hypercholesterolaemia: a prospective observational study using a lipoproteomic based approach;Bhandari;Lancet,2015

2. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial;Colhoun;Lancet,2004

3. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial;Sever;Drugs,2004

4. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials;Sattar;Lancet,2010

5. Statin therapy and risk of developing type 2 diabetes: a meta-analysis;Rajpathak;Diabetes Care,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential therapeutic strategies for MASH: from preclinical to clinical development;Life Metabolism;2024-07-06

2. A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action;Molecules;2024-04-19

3. Pitavastatin: A Comprehensive Overview of its Mechanisms, Pharmacokinetics, Pharmacodynamics, and Adverse Effects;2024-02-23

4. Nrf2/HO‐1, NF‐κB and PI3K/Akt signalling pathways decipher the therapeutic mechanism of pitavastatin in early phase liver fibrosis in rats;Journal of Cellular and Molecular Medicine;2024-01-12

5. Statins—From Fungi to Pharmacy;International Journal of Molecular Sciences;2023-12-29